Why confirm marker expression in live cells before colony selection?
Maintaining pluripotent human embryonic stem cells and deriving induced pluripotent stem cells require colony selection and cell expansion. Picking colonies that contain pluripotent stem cells is typically achieved by manually analyzing colony morphology. Unfortunately, this critical process is time-consuming and labor-intensive.
In addition, morphology-based colony selection does not consistently guarantee pluripotent starting populations, since cells can fail to be fully reprogrammed or can naturally differentiate within a colony.
To address this need, R&D Systems offers GloLIVE™ antibodies that allow researchers to confirm stem cell marker expression in live cells before colony selection.
Live pluripotent stem cell imaging:
Promotes the selection of high quality, undifferentiated stem cell colonies to reduce experimental variation.
Verifies stem cell pluripotency in 30 minutes, ensuring efficient use of time and reagents.
Allows for the continued culture of pluripotent cells with no adverse effects on cell proliferation or stemness following staining.
Supplied as 50X concentration of antibody in 0.5 mL PBS
Azide free and endotoxin tested (= 5 EU/mL), this antibody can be used for 12 tests, if a staining volume of 2 mL is used.
Data
Detection of SSEA-1 in Live D3 Mouse Embryonic Stem Cells. The stem cell marker SSEA-1 was visualized in live D3 mouse embryonic stem cells, grown on irradiated mouse embryonic fibroblasts (Catalog # PSC001), using a GloLIVE NL557-conjugated Anti-Human/Mouse SSEA-1 Monoclonal Antibody (Catalog # NLLC2155R; red). The nuclei were counterstained with Hoechst 33342 (blue). Positive staining for SSEA-1 in mouse stem cells is an indicator of pluripotency.
Stage-Specific Embryonic Antigen-1 (SSEA-1), an antigenic epitope defined as a Lewis x carbohydrate structure, is expressed during early mouse embryogenesis on murine embryonal carcinoma cells (EC), murine embryonic stem cells (ES), and murine and human germ cells. Expression of SSEA-1 is down-regulated following differentiation of murine EC and ES cells. In contrast, the differentiation of human EC and ES cells is accompanied by an increase in SSEA-1 expression (1, 2).
Product Specifications for GloLIVE Human/Mouse SSEA-1 NL557 Live Cell Antibody
Species
Human, Mouse
Applications
Immunocytochemistry/ Immunofluorescence
Scientific Data Examples for GloLIVE Human/Mouse SSEA-1 NL557 Live Cell Antibody
Detection of SSEA-1 in Live D3 Mouse Embryonic Stem Cells.
The stem cell marker SSEA-1 was visualized in live D3 mouse embryonic stem cells, grown on irradiated mouse embryonic fibroblasts (Catalog # PSC001), using a GloLIVE NL557-conjugated Anti-Human/Mouse SSEA-1 Monoclonal Antibody (Catalog # NLLC2155R; red). The nuclei were counterstained with Hoechst 33342 (blue). Positive staining for SSEA-1 in mouse stem cells is an indicator of pluripotency.
Preparation & Storage
Shipping Conditions
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8° C. Do not use past expiration date. Protect from light.
Assay Procedure
Refer to the product datasheet for complete product details.
Briefly, SSEA-1 expression can be verified in live cells prior to colony selection or experimentation using this simple procedure:
Add the SSEA-1 antibody directly to the media of cultured cells
To ensure sterility of cultures, all steps should be performed under sterile conditions.
Add fluorochrome-conjugated primary antibody in appropriate culture media to cells.
Incubate for 30 minutes.
Replace with fresh culture media.
Visualize using a fluorescence microscope.
Note: Culture with GloLIVE antibodies does not appear to affect cell proliferation or stemness as assayed by proliferation curves for 3 days post-antibody incubation and expression levels of SSEA-1 and Oct-3/4.
Bio-Techne uses cookies to provide you with a great website experience. By continuing to use this website you acknowledge this and agree to our cookie policy. Learn more.